Search - tctmd.com

Displaying 961 - 980 of 1248

Sort: Relevancy | Date

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

Caitlin E. Cox

May 22, 2013

News Industry News

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

May 20, 2013

News Daily News

Meta-analysis: Manual, Not Mechanical, Thrombectomy Holds Advantages Over PCI

May 17, 2013

News Daily News

Meta Análisis: Trombectomía Manual, No Mecánica ofrece Ventajas durante una PCI

May 17, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Jason Kahn

April 26, 2013

News Daily News

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Jason Kahn

April 26, 2013

News Daily News

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

L.A. McKeown

April 19, 2013

News Daily News

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

L.A. McKeown

April 19, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Las Hemorragias ‘Molestas’ tras un IAM son Frecuenten e Influyen en la Calidad de Vida

Yael L. Maxwell

March 28, 2013

News Daily News

‘Nuisance’ Bleeding After AMI Common, Affects QoL

Yael L. Maxwell

March 28, 2013

News Daily News

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

March 25, 2013

News Daily News

Remote Postconditioning Reduces AKI in NSTEMI Patients

March 15, 2013

News Daily News

Younger Women Fare Worse Than Men After PCI for STEMI

Jason Kahn

March 09, 2013

News Daily News

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

Yael L. Maxwell

March 09, 2013

Presentation ACC 2013

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardIal InfarctiON in Real Life: APPOSITION III Study

Presenter: Gilles Montalescot

March 08, 2013

News Industry News

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

March 08, 2013

News Industry News

STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

March 08, 2013

Advertisement

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

PRAGUE-19 Registry: Bioresorbable Scaffolds an Option for Certain STEMI Patients

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

Meta-analysis: Manual, Not Mechanical, Thrombectomy Holds Advantages Over PCI

Meta Análisis: Trombectomía Manual, No Mecánica ofrece Ventajas durante una PCI

Stroke After STEMI Unusual But Carries Poor Prognosis

Las Células Madre de la Médula Ósea No son Efectivas Antes ni Después de sufrir un IAM

Bone Marrow Stem Cells Not Effective Early or Late After AMI

Vorapaxar Substudy Shows Broad MI Reduction in High-Risk ACS Patients

Un Subestudio del Vorapaxar revela un Amplio Descenso de IM en Pacientes SCA de Alto Riesgo

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Las Hemorragias ‘Molestas’ tras un IAM son Frecuenten e Influyen en la Calidad de Vida

‘Nuisance’ Bleeding After AMI Common, Affects QoL

SCAAR Turns 20: PCI Expanded to Higher-Risk Patients with No Mortality Trade-off

Remote Postconditioning Reduces AKI in NSTEMI Patients

Younger Women Fare Worse Than Men After PCI for STEMI

Low-Dose Rivaroxaban Reduces Thrombotic Events, Increases Bleeding After STEMI

A Post-market Study to Assess the STENTYS Self-exPanding COronary Stent In AcuTe myocardIal InfarctiON in Real Life: APPOSITION III Study

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content